AMVUTTRA (VUTRISIRAN)

**Product type:** Human Prescription Drug

**Active ingredient:** VUTRISIRAN SODIUM

**Strength:** 25 mg/.5mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Alnylam Pharmaceuticals, Inc.

**Marketing category:** NDA (NDA215515)

**Pharmacologic class:** Decreased RNA Integrity [PE], Increased Protein Breakdown [PE], RNA, Small Interfering [CS], Small Interfering RNA [EPC], Transthyretin-directed RNA Interaction [EPC]